[Transmission of infectious diseases during imprisonment--results of a study and introduction of a model project for infection prevention in Lower Saxony] NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Transmission of infectious diseases during imprisonment--results of a study and introduction of a model project for infection prevention in Lower Saxony]

Gesundheitswesen. 1999 Apr;61(4):207-13. Unique Identifier : AIDSLINE MED/99336492
Keppler K; Stover H; Carl von Ossietzky-Universitat, Oldenburg.

Abstract: The increasing imprisonment rate of drug users is linked to a spread of infectious diseases in prisons (HIV and Hepatitis B and C). Several studies indicate a close correlation of imprisonment and transmission of infectious diseases. An analysis of international studies showed that worldwide in several cases transmissions of HIV-infection during imprisonment have been discovered. The cross-sectional examination presented here is describing the situation in the women's prison of Vechta (Lower-Saxony). Empirical data on the prevalence of infections with HIV, HBV, HCV and Lues of the years 1992 to 1994 were recorded. Moreover the scientific interest also included on the diagnosis of seroconversions. Discovered seroconversions were examinated on a possible transmission in custody. The spread of infectious diseases in prisons led to the demand for an alignment of internal drug aid services with external, tried and tested prophylaxis models. The availability of sterile syringes is included. The basic comparability of health care inside and outside prison (principle of equivalence) is not only demanded and recommended by the prison law [4] but also by international organisations [27]. As the first provencial government, the state of Lower Saxony in Germany has started to develop infection prophylaxis offers in two prisons (in the women's prison in Vechta since April 15th 1996 and in the men's prison of Lingen I, department Gross Hesepe since July 15th 1996) in 1996. These offers include the provision of sterile injection equipment to intravenous drug addicts (ivDA). Modalities of the practice and first experiences documented by the schientific evaluation are presented.
Keywords: JOURNAL ARTICLE Justizvollzug--Ergebnisse einer Untersuchung und Vorstellung eines Modellprojektes zur Infektionsprophylaxe in Niedersachsen. Adult Cross-Sectional Studies English Abstract Female Germany Hepatitis B/PREVENTION & CONTROL/*TRANSMISSION Hepatitis C/PREVENTION & CONTROL/*TRANSMISSION Human HIV Infections/PREVENTION & CONTROL/*TRANSMISSION Male Needle-Exchange Programs Pilot Projects *Prisons Retrospective Studies Risk Factors Substance Abuse, Intravenous/EPIDEMIOLOGY/REHABILITATION Syphilis/PREVENTION & CONTROL/TRANSMISSIONKWDjournalarticlejustizvollzug--ergebnisseeineruntersuchungundvorstellungeinesmodellprojekteszurinfektionsprophylaxeinniedersachsenKWDadultcross-sectionalstudiesenglishabstractfemalegermanyhepatitisb/prevention&control/KWDtransmissionhepatitisc/prevention&control/KWDtransmissionhumanhivinfections/prevention&control/KWDtransmissionmaleneedle-exchangeprogramspilotprojectsKWDprisonsretrospectivestudiesriskfactorssubstanceabuse,intravenous/epidemiology/rehabilitationsyphilis/prevention&control/transmission
991130
A99B1059

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .